Universe Pharmaceuticals INC (UPC)
- Previous Close
2.6600 - Open
2.5900 - Bid --
- Ask 2.6600 x 100
- Day's Range
2.5350 - 2.9500 - 52 Week Range
0.7500 - 5.8800 - Volume
86,419 - Avg. Volume
79,614 - Market Cap (intraday)
9.407M - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-1.7000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.
www.universe-pharmacy.com225
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: UPC
Performance Overview: UPC
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UPC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UPC
Valuation Measures
Market Cap
9.41M
Enterprise Value
-3.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.29
Price/Book (mrq)
0.24
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-19.08%
Return on Assets (ttm)
-3.91%
Return on Equity (ttm)
-14.34%
Revenue (ttm)
32.31M
Net Income Avi to Common (ttm)
-6.16M
Diluted EPS (ttm)
-1.7000
Balance Sheet and Cash Flow
Total Cash (mrq)
18.5M
Total Debt/Equity (mrq)
13.87%
Levered Free Cash Flow (ttm)
1.59M
Research Analysis: UPC
Company Insights: UPC
UPC does not have Company Insights